Binding of Iodine 125 -Bungarotoxin to the Thymus of Mice
- 1 January 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 35 (1) , 31-32
- https://doi.org/10.1001/archneur.1978.00500250035007
Abstract
• α-Bungarotoxin is known to bind with nicotinic acetylcholine receptors of skeletal muscle. Binding of iodine 125-labeled α-bungarotoxin to the murine thymus, muscle, and liver was estimated. The toxin was bound to the muscle. The thymus was also capable of binding a considerable amount of the toxin, and the binding was obviously blocked by tubocurarine chloride. Binding to the liver, an organ containing no nicotinic acetylcholine receptor, was very slight. These results may indicate the presence of nicotinic acetylcholine receptors in the thymus, which could have implications in the pathogenesis of myasthenia gravis. Degenerating myoid cells and their receptors may represent autoantigens that induce an immunological cross-reaction with the receptors of skeletal muscles, giving rise to myasthenia gravis.This publication has 8 references indexed in Scilit:
- A glycoprotein resembling a peripheral nicotinic acetylcholine receptor that binds [125I]-α-bungarotoxin in mouse brainNeuroscience Letters, 1977
- Thymic Muscle Cells Bear Acetylcholine Receptors: Possible Relation to Myasthenia GravisScience, 1977
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine ReceptorsScience, 1974
- Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine ReceptorsScience, 1973
- Autoimmune Response to Acetylcholine ReceptorScience, 1973
- THYMIC MYOID CELLS AND MYASTHENIA GRAVIS1970
- EXPERIMENTAL AUTOIMMUNE THYMITIS AN ANIMAL MODEL OF HUMAN MYASTHENIA GRAVISThe Lancet, 1966
- MYASTHENIA GRAVIS IMMUNOLOGICAL RELATIONSHIP BETWEEN STRIATED MUSCLE AND THYMUSThe Lancet, 1966